Ashburn Theodore 4
4 · Oncorus, Inc. · Filed Apr 9, 2021
Insider Transaction Report
Form 4
Oncorus, Inc.ONCR
Ashburn Theodore
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2020-12-31$1.81/sh+1,900$3,439→ 18,446 total - Exercise/Conversion
Employee Stock Option (right to buy)
2021-04-07−4,699→ 336,546 totalExercise: $5.32Exp: 2029-09-16→ Common Stock (4,699 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2020-12-31−1,900→ 331,975 totalExercise: $1.81Exp: 2028-11-13→ Common Stock (1,900 underlying) - Exercise/Conversion
Common Stock
2021-04-07$5.32/sh+4,699$24,999→ 23,145 total
Footnotes (2)
- [F1]Twenty-five percent (25%) of the shares subject to the option vested on July 16, 2019, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.
- [F2]Twenty-five percent (25%) of the shares subject to the option vested on September 17, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.